Exane Derivatives’s Atlassian TEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding TEAM
Exane Derivatives's TEAM Position: Q2 2022 in Review
Exane Derivatives reduced its Atlassian (TEAM) stake by 99% in Q2 2022, selling an estimated $131K and leaving 9 shares worth $1.69K. The position accounts for ﹤0.01% of the portfolio, ranked #456.
Exane Derivatives first reported a position in TEAM in Q1 2021 and has held it in 6 quarters since. The position peaked at $265K in Q4 2021. 663 funds tracked by Wall St. Rank hold TEAM as of Q2 2022.
- Exane Derivatives held 9 shares of Atlassian worth $1.69K as of Q2 2022.
- Exane Derivatives sold 615 Atlassian shares in Q2 2022, an estimated $131K.
- Atlassian made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #456 holding.
- Exane Derivatives first reported a position in Atlassian in Q1 2021 and has held it in 6 quarters since.
- Exane Derivatives's Atlassian position peaked at $265K in Q4 2021.
- 663 funds tracked by Wall St. Rank held Atlassian as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.